Orbus Pharma Inc.

Orbus Pharma Inc.

November 10, 2006 17:20 ET

Orbus CFO Announces Resignation to Pursue Other Business Interests

TORONTO, ONTARIO--(CCNMatthews - Nov. 10, 2006) - Orbus Pharma Inc. (TSX:ORB) ("Orbus") today announces that its Chief Financial Officer and Vice President of Finance Mr. Denis C. Arsenault, C.A. will be leaving Orbus at the end of November 2006 to pursue other business interests.

"Mr. Arsenault has been with Orbus since its foundation and the time and effort he has put into this business in the last five years has laid the ground work to our future success. His presence will be missed by everyone at Orbus and we wish him the best in his future endeavors" said Jeff Renwick, President and CEO of Orbus Pharma Inc.

Orbus Pharma Inc., listed on The Toronto Stock Exchange under the symbol ORB. Orbus pursues a strategy of generating revenue through the licensing of generic drug developments, as well as the manufacturing and selling of pharmaceutical products. For more information please visit www.orbus.ca.

Contact Information

  • Orbus Pharma Inc.
    Jeffrey W. Renwick
    President & CEO
    (905) 943-9444